Opioid-Related Disorders: all 1,439 studies

Page 6 of 15. Open to participants first (291), then studies with results posted, then the rest; newest registration first within each.

• Initiating Substance Use Disorder Treatment for Hospitalized Opioid Use Disorder Patients.CompletedNCT03212794Not applicableResults posted
• Medication Development for Opioid and Alcohol AbuseCompletedNCT03205423Phase 2Results posted
• Lorcaserin in Combination With XR-Naltrexone for Relapse Prevention in Opioid Use DisorderCompletedNCT03169816Phase 2/3Results posted
• Onsite Buprenorphine Treatment at Syringe Exchange ProgramsCompletedNCT03150173Phase 2Results posted
• Drug Interaction and Subjective Effects of Compounds for Opioid Use DisorderCompletedNCT03143855Phase 1Results posted
• The Life STORRIED StudyCompletedNCT03134092Not applicableResults posted
• Buprenorphine as Adjunct to Outpatient Induction Onto VivitrolTerminatedNCT03113409Phase 2/3Results posted
• Addiction, HIV and Tuberculosis in Malaysian Criminal Justice SettingsCompletedNCT03089983Not applicableResults posted
• Sofosbuvir/Velpatasvir in Postpartum Women With Opioid Use Disorder and Chronic Hepatitis C InfectionCompletedNCT03057847Phase 4Results posted
• Opioid Use Disorder in the Emergency Department: CTN 0069CompletedNCT03023930Not applicableResults posted
• Stimulant Oxytocin StudyCompletedNCT03016598Phase 2Results posted
• Feasibility Study of Extended-release Naltrexone (Vivitrol) in Drug Court SettingsCompletedNCT02978417Phase 4Results posted
• A Tailored, Peer-delivered Intervention to Reduce Recurring Opioid OverdosesCompletedNCT02922959Not applicableResults posted
• Open-Label Treatment Extension StudyCompletedNCT02896296Phase 3Results posted
• Smoking Cessation & Opioid Dependence Treatment IntegrationCompletedNCT02854800Phase 2/3Results posted
• A Patient-Centered Intervention to Improve Opioid SafetyCompletedNCT02791399Not applicableResults posted
• Change the Cycle: An RCT to Prevent Injection InitiationCompletedNCT02774954Not applicableResults posted
• Discontinuation vs Continuation of Long-term Opioid Therapy in Suboptimal and Optimal Responders With Chronic PainTerminatedNCT02741076Phase 4Results posted
• TAU Opioid Use Outcomes Following Discharge From Detoxification and Short Term Residential Programs Affiliated With CTN-0051CompletedNCT02730403Results posted
• Phase II Pharmacokinetics Study of CAM2038CompletedNCT02710526Phase 2Results posted
• Evaluating Naltrexone for Use in Conjunction With Buprenorphine in Adults With Opioid Use Disorder Transitioning From Buprenorphine Maintenance Prior to First Dose of VIVITROLCompletedNCT02696434Phase 3Results posted
• Neuroimaging Predictors of Relapse During Treatment for Opiate DependenceCompletedNCT02696096Phase 3Results posted
• Imaging the Effects of rTMS on Chronic PainTerminatedNCT02687360Not applicableResults posted
• Study of Opioid Use After Lumbar and Cervical Spine SurgeryCompletedNCT02674711Not applicableResults posted
• Long-Term Safety Study of Buprenorphine (CAM2038) in Adult Outpatients With Opioid Use DisorderCompletedNCT02672111Phase 3Results posted
• Naloxone Auto-injector as a Universal Precaution for Patients With Opioid Use DisorderCompletedNCT02669901Not applicableResults posted
• Establishing Efficacy of a Functional-Restoration Based CAM Pain Management Program in Post-9/11 VeteransCompletedNCT02657317Not applicableResults posted
• Clinical Trial of CAM2038, Long-acting Subcutaneous Buprenorphine Injections for Treatment of Patients With Opioid DependenceCompletedNCT02651584Phase 3Results posted
• Outcomes of Opioid Addicted Prisoners With Extended-Release Injectable NaltrexoneCompletedNCT02617628Phase 2/3Results posted
• Influence of Dexmedetomidine and Lidocaine on Opioid Consumption in Laparoscopic Intestine ResectionCompletedNCT02616523Phase 4Results posted
• A Multiple Dose Opioid Challenge StudyCompletedNCT02611752Phase 2Results posted
• Comparing Interventions for Opioid Dependent Patients Presenting in Medical Emergency DepartmentsCompletedNCT02586896Not applicableResults posted
• Oxytocin Treatment of Opioid DependenceCompletedNCT02548728Phase 1/2Results posted
• Improving Treatment Outcomes for Prescription Opioid DependenceCompletedNCT02543944Phase 2/3Results posted
• Acute and Short-term Effects of CBD on Cue-induced Craving in Drug-abstinent Heroin-dependent HumansCompletedNCT02539823Phase 2Results posted
• Naltrexone for Use in Conjunction With Buprenorphine in Adults With Opioid Use Disorder Prior to First Dose of VIVITROL® (Naltrexone for Extended-Release Injectable Suspension)CompletedNCT02537574Phase 3Results posted
• Buprenorphine Group Medical Visits in Primary CareCompletedNCT02526212Phase 3Results posted
• Safety and Tolerability Study of Depot Buprenorphine in Treatment Seeking Subjects With Opioid Use DisorderCompletedNCT02510014Phase 3Results posted
• Primary Care Intervention to Reduce Prescription Opioid OverdosesCompletedNCT02464410Not applicableResults posted
• Glutamatergic Modulation to Facilitate Naltrexone Initiation in Opioid DependenceCompletedNCT02437344Phase 2Results posted
• Improving Effective Contraceptive Use Among Opioid-maintained Women: Stage IICompletedNCT02411357Not applicableResults posted
• The Effects of Minocycline in Opioid-maintained PatientsCompletedNCT02359006Not applicableResults posted
• Treatment Seeking Participants With Opioid Use Disorders Assessing Tolerability of Depot Injections of BuprenorphineCompletedNCT02357901Phase 3Results posted
• A Randomized Trial of Interim Methadone and Patient Navigation Initiated in JailCompletedNCT02334215Not applicableResults posted
• Buprenorphine/Naloxone Stabilization and Induction Onto Injection NaltrexoneCompletedNCT02294253Phase 2/3Results posted
• Study of Treatment for Opioid Dependence and Anxiety DisordersCompletedNCT02252068Not applicableResults posted
• Buprenorphine Treatment for Opioid DependenceCompletedNCT02187198Phase 3Results posted
• A Study of Adult Outpatients With Opioid Dependence Transitioned From a Daily SL Buprenorphine to Probuphine® Subdermal ImplantsCompletedNCT02180659Phase 3Results posted
• Injectable Pharmacotherapy for Opioid Use Disorders (IPOD)CompletedNCT02110264Phase 3Results posted
• Multiple Dose Study of Blockade of Opioid Effects by Injections of Buprenorphine in Participants With Opioid DisorderCompletedNCT02044094Phase 2Results posted
• Usability of Zubsolv Sublingual Tablets 5.7/1.4 to Suboxone Sublingual Film 8/2 In Buprenorphine/Naloxone Treated Opioid Dependent PopulationCompletedNCT02038790Phase 4Results posted
• Extended-Release Naltrexone vs. Buprenorphine for Opioid TreatmentCompletedNCT02032433Phase 4Results posted
• Extended-Release Naltrexone Opioid Treatment at Jail Re-EntryCompletedNCT01999946Phase 4Results posted
• Prescription Opioid Abuse Among Pain Patients: Predictors of RelapseCompletedNCT01967641Phase 2Results posted
• Efficacy of BNX Sublingual Tablets Versus BNX Sublingual Film for Treatment of Opioid-Dependent AdultsCompletedNCT01908842Phase 3Results posted
• Comparing Treatments for HIV-Infected Opioid and Alcohol Users in an Integrated Care Effectiveness StudyCompletedNCT01908062Phase 3Results posted
• Multi-Center, Open-Label, 24-Week Study of OX219 Safety and Efficacy for Maintenance Treatment of Opioid DependenceCompletedNCT01903005Phase 4Results posted
• Improving Buprenorphine Detoxification Outcomes With IsradipineCompletedNCT01895270Phase 1/2Results posted
• Nalrexone Facilitated Discontinuation of BuprenorphineCompletedNCT01895036Phase 1/2Results posted
• Safety & Prevention Outcomes StudyCompletedNCT01894087Not applicableResults posted
• Clomiphene Citrate for the Treatment of Low Testosterone Associated With Chronic Opioid Pain Medication AdministrationCompletedNCT01880086Phase 2Results posted
• Testosterone Replacement for Male Opioid Agonist Maintained PatientsCompletedNCT01873989Phase 1/2Results posted
• Efficacy, Safety and Dose-Response Study Followed by Open-Label Study of Lofexidine Treatment of Opioid WithdrawalCompletedNCT01863186Phase 3Results posted
• Study to Assess Efficacy and Safety of BNX Sublingual Tablets for the Induction of Treatment of Opioid DependenceCompletedNCT01848054Phase 3Results posted
• Dane County Drug Court Study for Addicted OffendersCompletedNCT01843751Phase 3Results posted
• Buprenorphine Treatment: A Safe Alternative for Opioid Dependent Pain PatientsTerminatedNCT01841931Phase 4Results posted
• A Drug Treatment for Cocaine Users Who Are Also on Methadone Maintenance TreatmentTerminatedNCT01802515Not applicableResults posted
• Abuse Potential of Intranasal VYCAVERT Tablets (Hydrocodone Bitartrate/Acetaminophen) in Recreational Opioid UsersCompletedNCT01759446Phase 2Results posted
• Testing a Community-Friendly Risk Reduction Intervention for Injection Drug UsersCompletedNCT01741350Not applicableResults posted
• Effects of Ibudilast on Oxycodone Self-administration in Opioid AbusersCompletedNCT01740414Phase 2Results posted
• Multiple Dose Pharmacokinetics Depot Buprenorphine in Opioid-Dependent SubjectsCompletedNCT01738503Phase 2Results posted
• Completion of OST - a Prospective StudyCompletedNCT01722435Results posted
• Low Dose Naltrexone-buprenorphine Transfer to Vivitrol Injection in Opioid DependenceCompletedNCT01690546Phase 2Results posted
• An Open Label Study To Assess The Safety And Tolerability Of BEMA® Buprenorphine NX In Opioid Dependent SubjectsCompletedNCT01666119Phase 2Results posted
• Acute and Short-term Effects of Cannabidiol Admin on Cue-induced Craving in Drug-abstinent Heroin Dependent HumansCompletedNCT01605539Phase 2Results posted
• The Separate and Combined Effects of Vivitrol and Opiate Abstinence Reinforcement in the Treatment of Opioid DependenceCompletedNCT01556425Phase 2Results posted
• HIV, Buprenorphine, and the Criminal Justice SystemCompletedNCT01550341Not applicableResults posted
• A Study of VIVITROL in the Prevention of Re-arrest and Re-incarcerationCompletedNCT01453374Phase 4Results posted
• Reengineering Methadone Treatment Study of Patient-centered Methadone TreatmentCompletedNCT01442493Not applicableResults posted
• A Bridge to Treatment: The Therapeutic Workplace and Methadone TreatmentCompletedNCT01416584Not applicableResults posted
• Effects of Pioglitazone, a PPARgamma Receptor Agonist, on the Abuse Liability of OxycodoneCompletedNCT01395784Phase 2Results posted
• Developing a Smoking Cessation Intervention for Methadone Maintained SmokersCompletedNCT01393392Phase 1Results posted
• Abuse Potential of Orally Administered Crushed Embeda Compared to Crushed Controlled-Release Morphine and Placebo in Non-Dependent Recreational Opioid UsersCompletedNCT01380093Phase 1Results posted
• Clonidine to Treat Iatrogenic-induced Opioid Dependence in InfantsTerminatedNCT01360450Phase 2/3Results posted
• Effects of Gabapentin Versus Placebo on Buprenorphine Detoxification of Opioid-dependent IndividualsCompletedNCT01262092Phase 2Results posted
• Naltrexone for Opioid Dependent Released Human Immunodeficiency Virus Positive (HIV+) Criminal Justice PopulationsCompletedNCT01246401Phase 1/2Results posted
• ALK21-004: Single-dose Opiate Challenge of Medisorb® Naltrexone (VIVITROL®) in Adults Who Use OpioidsCompletedNCT01218984Phase 2Results posted
• Methadone Monitoring for Insights Into Adverse EventsCompletedNCT01191242Results posted
• Medications Development for Drug Abuse DisordersCompletedNCT01188421Phase 1/2Results posted
• Extended-Release Naltrexone for Opioid Relapse Prevention Following Release From JailCompletedNCT01180647Phase 3Results posted
• A Within Subject Comparison of Opioid Withdrawal in Opioid Dependent IndividualsCompletedNCT01136356Phase 1/2Results posted
• Memantine-enhanced Buprenorphine Treatment for Opioid-dependent Young AdultsCompletedNCT01052662Phase 2/3Results posted
• Study of the Relative Abuse Potential of Acurox Tablets in Non-Dependent Recreational Opioid UsersCompletedNCT01030406Phase 2Results posted
• Dronabinol Naltrexone Treatment for Opioid DependenceCompletedNCT01024335Phase 2/3Results posted
• Methylnaltrexone for Opioid-induced Constipation in Cancer PatientsCompletedNCT01004393Phase 2Results posted
• Efficacy of Computer Delivered Community Reinforcement Approach (CRA) (Bup II)CompletedNCT00929253Not applicableResults posted
• Models of Screening, Brief Intervention With a Facilitated Referral to Treatment (SBIRT) for Opioid Patients in the Emergency DepartmentCompletedNCT00913770Not applicableResults posted
• Buprenorphine and Methadone for Opioid Dependent Chronic Pain PatientsCompletedNCT00879996Phase 4Results posted
• ALK21-021: A Safety Study of Medisorb® Naltrexone (VIVITROL®) Administered to Health Care ProfessionalsCompletedNCT00834080Phase 3Results posted
• Treatment Study Using Depot Naltrexone (1/6) Philadelphia Coord/Data Mgmt SiteCompletedNCT00781898Phase 2/3Results posted

← Opioid-Related Disorders overview